Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 19.92%-4.87M | ---- | 28.80%-6.08M | ---- | -244.49%-8.55M | ---- | -71.82%5.91M | ---- | 144.09%20.99M |
| Profit adjustment | ||||||||||
| Dividend (income)- adjustment | ---- | -44.00%-36K | ---- | 74.49%-25K | ---- | -42.03%-98K | ---- | ---69K | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | -53.09%-1.56M | ---- | -669.27%-1.02M | ---- | -86.92%179K | ---- | 28.33%1.37M | ---- | 156.19%1.07M |
| Impairment and provisions: | ---- | -96.70%65K | ---- | 26.49%1.97M | ---- | -76.62%1.56M | ---- | 873.58%6.67M | ---- | -52.53%685K |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.4M | ---- | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.09M | ---- | ---- |
| -Other impairments and provisions | ---- | -96.70%65K | ---- | 26.49%1.97M | ---- | 742.70%1.56M | ---- | -72.99%185K | ---- | -52.53%685K |
| Revaluation surplus: | ---- | -504.35%-1.67M | ---- | -73.70%414K | ---- | -61.55%1.57M | ---- | 311.25%4.09M | ---- | -128.00%-1.94M |
| -Other fair value changes | ---- | -504.35%-1.67M | ---- | -73.70%414K | ---- | -61.55%1.57M | ---- | 311.25%4.09M | ---- | -128.00%-1.94M |
| Asset sale loss (gain): | ---- | -100.79%-36K | ---- | 124.57%4.56M | ---- | 3,175.81%2.03M | ---- | -88.26%62K | ---- | -60.15%528K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | -91.42%155K | ---- | --1.81M | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -100.82%-36K | ---- | 1,866.96%4.41M | ---- | 261.29%224K | ---- | -88.26%62K | ---- | -60.15%528K |
| Depreciation and amortization: | ---- | 6.14%32.94M | ---- | 3.24%31.03M | ---- | 2.92%30.06M | ---- | -8.22%29.21M | ---- | -8.39%31.82M |
| -Amortization of intangible assets | ---- | ---- | ---- | ---- | ---- | 201.08%280K | ---- | --93K | ---- | ---- |
| Financial expense | ---- | 0.11%3.52M | ---- | 136.11%3.52M | ---- | 37.96%1.49M | ---- | -30.46%1.08M | ---- | -25.69%1.55M |
| Exchange Loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --171K |
| Special items | ---- | 78.79%-1.06M | ---- | -138.43%-5.01M | ---- | 306.30%13.03M | ---- | -89.50%-6.32M | ---- | -13.91%-3.33M |
| Operating profit before the change of operating capital | ---- | -7.08%27.28M | ---- | -28.87%29.36M | ---- | -1.74%41.28M | ---- | -18.50%42.01M | ---- | 2.50%51.55M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -323.53%-5.1M | ---- | 29.07%2.28M | ---- | 159.97%1.77M | ---- | -1,490.57%-2.95M | ---- | 127.46%212K |
| Accounts receivable (increase)decrease | ---- | 113.84%119K | ---- | -1,094.44%-860K | ---- | -108.20%-72K | ---- | 155.46%878K | ---- | -134.85%-1.58M |
| Accounts payable increase (decrease) | ---- | -136.52%-12.02M | ---- | -166.89%-5.08M | ---- | 3.25%7.6M | ---- | 202.09%7.36M | ---- | 126.16%2.44M |
| prepayments (increase)decrease | ---- | -132.09%-747K | ---- | -66.08%2.33M | ---- | 195.12%6.86M | ---- | -399.54%-7.22M | ---- | 58.07%2.41M |
| Special items for working capital changes | ---- | --5.92M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from business operations | -39.35%6.11M | -44.85%15.46M | 237.00%10.08M | -51.20%28.03M | -119.03%-7.35M | 43.30%57.44M | 111.81%38.64M | -27.15%40.08M | -34.54%18.24M | 18.91%55.02M |
| Other taxs | -102.91%-209K | -218.48%-891K | 84.39%-103K | 128.60%752K | 22.90%-660K | 8.11%-2.63M | -4.14%-856K | 7.26%-2.86M | 25.61%-822K | -15.54%-3.09M |
| Interest paid - operating | 6.60%-976K | -50.43%-1.94M | -114.58%-1.05M | -82.84%-1.29M | -83.08%-487K | -62.07%-705K | -32.34%-266K | 3.33%-435K | 13.73%-201K | 27.54%-450K |
| Net cash from operations | -44.83%4.93M | -54.07%12.63M | 205.01%8.93M | -49.19%27.49M | -122.66%-8.5M | 47.07%54.1M | 117.88%37.51M | -28.55%36.79M | -35.09%17.22M | 19.79%51.48M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -42.05%561K | -67.18%1.63M | -60.90%968K | 26.46%4.95M | 72.06%2.48M | 34.57%3.92M | -0.96%1.44M | -6.16%2.91M | 2.25%1.45M | -9.06%3.1M |
| Dividend received - investment | -50.00%18K | 44.00%36K | --36K | -97.53%25K | ---- | --1.01M | ---- | ---- | ---- | --785K |
| Sale of fixed assets | ---- | -77.79%486K | -84.95%133K | 651.89%2.19M | 12,528.57%884K | 29,000.00%291K | --7K | -99.48%1K | ---- | -38.19%191K |
| Purchase of fixed assets | 92.71%-2.27M | -5.15%-32.57M | -195.22%-31.21M | -25.01%-30.97M | -43.24%-10.57M | -103.08%-24.77M | -168.66%-7.38M | -206.74%-12.2M | -0.66%-2.75M | 19.00%-3.98M |
| Sale of subsidiaries | ---- | ---- | ---- | -99.19%3K | ---- | --371K | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | 118.66%5.38M | ---- | ---28.83M | ---618K | ---- | ---- | ---5.79M | ---- | ---- |
| Recovery of cash from investments | ---- | 140.91%17.41M | --8M | 33.69%7.23M | ---- | -59.17%5.41M | -71.23%3.34M | -19.51%13.24M | 54.10%11.61M | 3,099.81%16.45M |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | 88.23%-1M | ---- | 79.02%-8.5M | 89.72%-3M | -35.85%-40.52M |
| Other items in the investment business | ---- | ---- | --5.38M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 89.84%-1.7M | 83.20%-7.63M | -113.19%-16.69M | -207.23%-45.41M | -201.81%-7.83M | -42.94%-14.78M | -135.47%-2.59M | 56.86%-10.34M | 132.10%7.31M | 21.42%-23.97M |
| Net cash before financing | 141.60%3.23M | 127.89%5M | 52.46%-7.76M | -145.56%-17.92M | -146.77%-16.33M | 48.69%39.32M | 42.35%34.92M | -3.89%26.45M | 555.18%24.53M | 120.54%27.52M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -49.61%26M | -1.17%70.71M | -25.33%51.6M | 267.03%71.55M | 3,094.96%69.11M | -30.54%19.49M | -49.18%2.16M | 876.85%28.07M | 235.91%4.26M | -58.34%2.87M |
| Refund | 9.34%-38.33M | 11.46%-47.17M | 13.73%-42.27M | -132.68%-53.28M | -936.60%-49M | -4.39%-22.9M | -87.21%-4.73M | -431.65%-21.94M | -8.32%-2.53M | 64.68%-4.13M |
| Interest paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 28.56%-1.1M |
| Dividends paid - financing | ---- | ---225K | ---- | ---- | ---- | -12.50%-4.95M | ---- | ---4.4M | ---- | ---- |
| Net cash from financing operations | -704.26%-24.92M | 70.21%-2.08M | -141.93%-3.1M | 75.09%-7M | 159.99%7.39M | -46.48%-28.09M | -47.92%-12.32M | 14.97%-19.17M | 31.33%-8.33M | 33.34%-22.55M |
| Effect of rate | -61.69%95K | 238.46%108K | -10.47%248K | 37.10%-78K | 253.04%277K | -267.57%-124K | -406.78%-181K | 0.00%74K | -69.11%59K | 109.40%74K |
| Net Cash | -99.65%-21.69M | 111.69%2.91M | -21.47%-10.86M | -321.69%-24.91M | -139.56%-8.94M | 54.52%11.24M | 39.49%22.6M | 46.44%7.27M | 293.34%16.2M | 123.26%4.97M |
| Begining period cash | 3.02%103.06M | -19.99%100.04M | -19.99%100.04M | 9.76%125.02M | 9.76%125.02M | 6.89%113.91M | 6.89%113.91M | 4.96%106.57M | 4.96%106.57M | -17.90%101.53M |
| Cash at the end | -8.90%81.47M | 3.02%103.06M | -23.15%89.42M | -19.99%100.04M | -14.65%116.36M | 9.76%125.02M | 11.00%136.33M | 6.89%113.91M | 31.60%122.83M | 4.96%106.57M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PwC | -- | PwC | -- | PwC | -- | PwC | -- | PwC |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.